
Spark Biomedical Completes Enrollment for Pivotal Trial in Neonatal Opioid Withdrawal Treatment
Dallas, TX, March 24, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal phase II clinical trial, offering hope to newborns with Neonatal Opioid Withdrawal Syndrome (NOWS). …